MedTrace Logo

AI-Powered ECG Detecting Culprit Vessel Blood Flow Abnormality in ACS

NCT06528821 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2026-03-20

No results posted yet for this study

Summary

AI ECG TIMI is an investigator-initiated, international, and multicenter registry of acute coronary syndrome patients aimed to identify electrocardiographic findings detected by an AI model predicting coronary blood flow alteration. The aim of the study is to identify electrocardiographic findings detected by an automated artificial intelligence (AI) model that can predict coronary blood flow alteration as assessed by the TIMI grade flow at the very moment of the invasive coronary angiography in patients with acute coronary syndromes.

Conditions

  • Acute Coronary Syndrome
  • STEMI
  • Coronary Occlusion
  • Coronary Syndrome
  • NSTEMI
  • NSTEMI - Non-ST Segment Elevation MI

Sponsors & Collaborators

  • Powerful Medical

    lead OTHER

Principal Investigators

  • Robert Herman, MD, PhD · Powerful Medical

  • Emanuele Barbato, MD, PhD · University of Roma La Sapienza

  • Jozef Bartunek, MD, PhD · Azorg Hospital, Aalst

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-10
Primary Completion
2026-03-16
Completion
2026-05-16

Countries

  • Austria
  • Belgium
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06528821 on ClinicalTrials.gov